EGFR mutations and ALK rearrangements have been described in cases of histological transformation as a mechanism of resistance to tyrosine kinase inhibitors (TKIs) [11,32,33,34], but de novo alterations of these genes in SCLC are unusual. The gene discussed is ALK; the disease is small cell lung carcinoma.